What does change in fair value of holdback shares mean?

This reflects the periodic adjustment to the carrying value of equity instruments held back as part of a business combination or acquisition agreement. Changes in fair value represent market-based revaluations that impact the company's financial position without immediate cash flow implications.

TuHURA Biosciences, Inc. HURA Change In Fair Value Of Holdback Shares

Change In Fair Value Of Holdback Shares at other companies

Tempus AI, Inc.TEM

-$1.17M-2,637%

QCR HoldingsQCRH

-$462.75K-162%

CEP

Cantor Equity Partners II, Inc. Class A Ordinary ShareCEPT

$1.17M—

CEP

Cantor Equity Partners I, Inc. Class A Ordinary SharesCEPO

-$5.71M—

NioCorp Developments Ltd.NB

$515.75K+131%

Montana Technologies CorporationAIRJ

-$441K+91.9%

Other financials

Income statement

See full

Revenue-—

Net income-$7.5M-13.1%

EPS (diluted)-$0.13+13.3%

Balance sheet

See full

Cash & equivalents$6.3M+1.3%

Total debt$456.9K+178%

Total equity$23.2M+135%

Total assets$29.7M+103%

Cash flow

See full

Operating cash flow-$4.4M+6.9%

CapEx$48.8K+14.5%

Free cash flow-$4.5M+6.7%

Valuation

See full

Market cap$155.39M+45.8%

Enterprise value$149.54M+52.3%

Returns & leverage

See full

Return on equity-187.2%—

Debt / equity0×0.0×

Current ratio1.2×-1.8×

Where this comes from

Reported directly by TuHURA Biosciences, Inc. in its filing.

Tagged under the XBRL concept hura:ChangeInFairValueOfHoldbackShares.

The official record: TuHURA Biosciences, Inc.’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about TuHURA Biosciences, Inc.'s change in fair value of holdback shares.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TuHURA Biosciences, Inc.'s change in fair value of holdback shares?: TuHURA Biosciences, Inc. (HURA) reported change in fair value of holdback shares of -$397.74K in Q4 2025.
What does change in fair value of holdback shares mean?: This reflects the periodic adjustment to the carrying value of equity instruments held back as part of a business combination or acquisition agreement. Changes in fair value represent market-based revaluations that impact the company's financial position without immediate cash flow implications.